Serial 90735645
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90735645
- Registration number
- 7001484
- Mark type
- Design / logo
- Filed
- 26 May 2021
- Published for opposition
- 03 May 2022
- Registered
- 14 Mar 2023
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis and monitoring of cancer
- Class 044 — Medical, beauty and agricultural services: providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services
Owner
- Progenics Pharmaceuticals, Inc., Bedford, MA, US
- Progenics Pharmaceuticals, Inc., Bedford, MA, US
- Progenics Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Dec 2022 — USE AMENDMENT FILED
- 26 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 28 Jun 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 May 2022 — PUBLISHED FOR OPPOSITION
- 13 Apr 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE